Our Lady of the Lake Cancer Institute announced it has received the Excellence in Early Detection Award from the Eon Center of Excellence. This recognition highlights Our Lady of the Lake Cancer Institute’s investments in comprehensive lung cancer programs, including a focus on community and primary care physician outreach, implementation of advanced screening technologies, and incidental lung nodule management, enhancing early-stage cancer detection.
November 14, 2024
Alzheimer’s Services of the Capital Area and YMCA will offer in-person memory screenings at the Paula G. Manship YMCA, 8100 YMCA Plaza Dr. in Baton Rouge on Nov. 22.
The event will run from 9 a.m.-12 p.m. Walk-ins are welcome.
Persons who may wish to participate would include anyone who is concerned about memory loss or experiencing warning signs of dementia; or anybody at risk due to related illness or family history.
November 14, 2024
Ochsner Health welcomed several new providers to the Baton Rouge region:
Katrece Barber, NP, practices family medicine at Ochsner Medical Complex – The Grove. She earned bachelor’s and master’s degrees in nursing from Southern University in Baton Rouge. She completed clinical rotations in pediatrics, women’s health, urgent care, cardiovascular disease, and family medicine. Before joining Ochsner, Barber worked as a nurse practitioner in urgent care settings across the Baton Rouge area.
November 14, 2024
Ochsner Health announced that Ben Bordelon, president and CEO of Bollinger Shipyards, LLC, has been elected to serve as a board member for its 46-hospital health system. Bordelon will begin his four-year term effective January 1, 2025.
The Ochsner Health Board of Directors oversees the system’s leadership and strategy to achieve the organization’s mission and vision.
November 7, 2024
This article by Lorena O’Neil was published in Louisiana Illuminator on Oct. 31, 2024
Health care workers and advocates filed a lawsuit Thursday against the state of Louisiana, on their own and on behalf of their patients, challenging Act 246, a new state law reclassifying mifepristone and misoprostol as controlled dangerous substances.
- ‹ previous
- 71 of 606
- next ›